A new global standard in biomedical coatings.

TekCyte is a world leader in the development and manufacture of advanced coatings for medical devices and biomedical applications.
hico-banner-icon
Coating Creation & Testing
hico-banner-icon2
Manufacturing Capabilities
hico-banner-icon3
Commercially Scalable

Introducing BIOINVISIBLE™ a superior biocompatible coating for medical devices that can dramatically improve performance, using our unique patented coating process.

When coated onto implantable materials, BIOINVISIBLE™ renders them ‘invisible’ to the body’s normal immune defences.

The world’s most advanced hyperbranched polyglycerol coating that can be applied at commercial scale.

A trusted medical device supply partner world-wide

As experts in coatings for biomedical applications, TekCyte creates world-leading surface coating technologies that enhance the performance and safety of medical devices.

Our best-in-class manufacturing facility produces high-quality, low-cost coatings for medical device manufacturers.

Advanced coatings

Benefits of BIOINVISIBLE™ for medical device manufacturers.

Many other commercial medical coating technologies are expensive, have inadequate biocompatibility, or are not applicable to a wide range of device materials. BIOINVISIBLE™ is the answer to these issues.

Industry leading services and capabilities

We provide a range of bespoke services and custom-made coatings to the medical device and biomedical research industries. Our combination of biological and biomaterials expertise means our team can design ultra-thin, scalable coatings tailored to specific needs and requirements.

Our industry leading manufacturing capabilities include state-of-the-art cleanrooms and scalable equipment supported by an established quality framework aligned to ISO 13485.

Ourpartner Bg Full

Our partnerships

We create and test biologically functional coatings for companies pioneering the medical device and biomedical industry.
Cell Delivery Technology

CYPATCH - a patented TekCyte coating is exclusively licensed to Cynata Therapeutics Limited.

This coating allows for the delivery of therapeutic stem cells from wound dressings onto damaged tissue such as a wound, increasing the rate of healing.

Cynata will undertake a human clinical trial using CYPATCH-coated dressings to deliver their Cymerus® cells to treat chronic diabetic wounds. TekCyte will work with Cynata to manufacture and supply the CYPATCH-coated active dressing for the first trial.

Tekcyte Partner
Tekcyte
Email Us
Pop Img 1
Pop Bioinvisible
Discover more about our flagship product BIOINVISIBLE™
This field is for validation purposes and should be left unchanged.
Enquiry Form
This field is for validation purposes and should be left unchanged.

Share This

Select your desired option below to share a direct link to this page.
Your friends or family will thank you later.

Share on facebook
Share on twitter
Share on linkedin
Share on pinterest
Share on email